MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, C.-H.
Right arrow Articles by Gean, P.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, C.-H.
Right arrow Articles by Gean, P.-W.

Vol. 63, Issue 1, 44-52, January 2003

Involvement of a Calcineurin Cascade in Amygdala Depotentiation and Quenching of Fear Memory

Chia-Ho Lin, Chia-Ching Lee, and Po-Wu Gean

Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan, Taiwan

If fear memory is expressed by a long-term potentiation (LTP) of synaptic transmission in the amygdala, then reversal of LTP (depotentiation) in this area of the brain may provide an important mechanism for amelioration of anxiety and post-traumatic stress disorder. Herein, we show that low-frequency stimulation (LFS) of the external capsule elicits a depotentiation in the lateral nucleus of the amygdala. The induction of depotentiation requires activation of N-methyl-D-aspartate receptors and voltage-dependent calcium channels but is independent of adenosine A1 and metabotropic glutamate group II receptors. Extracellular perfusion or loading cells with protein phosphatase (PP) 2B (calcineurin) inhibitors prevents depotentiation. The same stimulating protocol applied to the amygdala in vivo attenuates the expression of fear memory measured with fear-potentiated startle and reduces conditioning-elicited phosphorylation of Akt and mitogen-activated protein kinase (MAPK). This is paralleled by an increase in the activity of calcineurin. In addition, application of calcineurin inhibitor blocks LFS-induced extinction of fear memory and MAPK dephosphorylation. Taken together, this study characterizes the properties of LFS-induced depotentiation in the amygdala and suggests an involvement of calcineurin cascade in synaptic plasticity and memory storage.

Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 ScienceHome page
N. Gogolla, P. Caroni, A. Luthi, and C. Herry
Perineuronal Nets Protect Fear Memories from Erasure
Science, September 4, 2009; 325(5945): 1258 - 1261.
[Abstract] [Full Text] [PDF]

Home page
 Learn. Mem.Home page
A. M. Woods and M. E. Bouton
Immediate extinction causes a less durable loss of performance than delayed extinction following either fear or appetitive conditioning
Learn. Mem., December 2, 2008; 15(12): 909 - 920.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. J. Sajdyk, P. L. Johnson, R. J. Leitermann, S. D. Fitz, A. Dietrich, M. Morin, D. R. Gehlert, J. H. Urban, and A. Shekhar
Neuropeptide Y in the Amygdala Induces Long-Term Resilience to Stress-Induced Reductions in Social Responses But Not Hypothalamic-Adrenal-Pituitary Axis Activity or Hyperthermia
J. Neurosci., January 23, 2008; 28(4): 893 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Maren and C.-h. Chang
Recent fear is resistant to extinction
PNAS, November 21, 2006; 103(47): 18020 - 18025.
[Abstract] [Full Text] [PDF]

Home page
 TraumatologyHome page
T. Rasolkhani-Kalhorn and M. L. Harper
EMDR and Low Frequency Stimulation of the Brain
Traumatology, March 1, 2006; 12(1): 9 - 24.
[Abstract] [PDF]

Home page
 Learn. Mem.Home page
M. Barad
Is extinction of fear erasure or inhibition? Why both, of course.
Learn. Mem., March 1, 2006; 13(2): 108 - 109.
[Full Text] [PDF]

Home page
 Learn. Mem.Home page
K. M. Myers, K. J. Ressler, and M. Davis
Different mechanisms of fear extinction dependent on length of time since fear acquisition.
Learn. Mem., March 1, 2006; 13(2): 216 - 223.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Belmeguenai and C. Hansel
A Role for Protein Phosphatases 1, 2A, and 2B in Cerebellar Long-Term Potentiation
J. Neurosci., November 16, 2005; 25(46): 10768 - 10772.
[Abstract] [Full Text] [PDF]

Home page
 Learn. Mem.Home page
C. K. Cain, B. P. Godsil, S. Jami, and M. Barad
The L-type calcium channel blocker nifedipine impairs extinction, but not reduced contingency effects, in mice
Learn. Mem., May 1, 2005; 12(3): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Learn. Mem.Home page
C.-H. Lin, C.-C. Lee, Y.-C. Huang, S.-J. Wang, and P.-W. Gean
Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats
Learn. Mem., March 1, 2005; 12(2): 130 - 137.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
A. E. Dityatev and V. Y. Bolshakov
Amygdala, Long-term Potentiation, and Fear Conditioning
Neuroscientist, February 1, 2005; 11(1): 75 - 88.
[Abstract] [PDF]

Home page
 Learn. Mem.Home page
F. Sotres-Bayon, D. E.A. Bush, and J. E. LeDoux
Emotional Perseveration: An Update on Prefrontal-Amygdala Interactions in Fear Extinction
Learn. Mem., September 1, 2004; 11(5): 525 - 535.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics